Literature DB >> 28251937

Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.

Didier Brassard1,2, Maude Tessier-Grenier1,2, Janie Allaire1,2, Ethendhar Rajendiran3, Yongbo She3, Vanu Ramprasath3, Iris Gigleux1,2, Denis Talbot4, Emile Levy1,5, Angelo Tremblay1,6, Peter Jh Jones3, Patrick Couture1,7, Benoît Lamarche8,2.   

Abstract

Background: Controversies persist concerning the association between intake of dietary saturated fatty acids (SFAs) and cardiovascular disease risk.Objective: We compared the impact of consuming equal amounts of SFAs from cheese and butter on cardiometabolic risk factors.Design: In a multicenter, crossover, randomized controlled trial, 92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrations were assigned to sequences of 5 predetermined isoenergetic diets of 4 wk each separated by 4-wk washouts: 2 diets rich in SFAs (12.4-12.6% of calories) from either cheese or butter; a monounsaturated fatty acid (MUFA)-rich diet (SFAs: 5.8%, MUFAs: 19.6%); a polyunsaturated fatty acid (PUFA)-rich diet (SFAs: 5.8%, PUFAs: 11.5%); and a low-fat, high-carbohydrate diet (fat: 25%, SFAs: 5.8%).
Results: Serum HDL-cholesterol concentrations were similar after the cheese and butter diets but were significantly higher than after the carbohydrate diet (+3.8% and +4.7%, respectively; P < 0.05 for both). LDL-cholesterol concentrations after the cheese diet were lower than after the butter diet (-3.3%, P < 0.05) but were higher than after the carbohydrate (+2.6%), MUFA (+5.3%), and PUFA (+12.3%) diets (P < 0.05 for all). LDL-cholesterol concentrations after the butter diet also increased significantly (from +6.1% to +16.2%, P < 0.05) compared with the carbohydrate, MUFA, and PUFA diets. The LDL-cholesterol response to treatment was significantly modified by baseline values (P-interaction = 0.02), with the increase in LDL cholesterol being significantly greater with butter than with cheese only among individuals with high baseline LDL-cholesterol concentrations. There was no significant difference between all diets on inflammation markers, blood pressure, and insulin-glucose homeostasis.Conclusions: The results of our study suggest that the consumption of SFAs from cheese and butter has similar effects on HDL cholesterol but differentially modifies LDL-cholesterol concentrations compared with the effects of carbohydrates, MUFAs, and PUFAs, particularly in individuals with high LDL cholesterol. In contrast, SFAs from either cheese or butter have no significant effects on several other nonlipid cardiometabolic risk factors. This trial was registered at clinicaltrials.gov as NCT02106208.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  CVD; SFA; cardiovascular risk factors; dairy products; men and women; randomized crossover controlled trial

Mesh:

Substances:

Year:  2017        PMID: 28251937     DOI: 10.3945/ajcn.116.150300

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  27 in total

Review 1.  Nutrition and Cardiovascular Disease-an Update.

Authors:  Kate J Bowen; Valerie K Sullivan; Penny M Kris-Etherton; Kristina S Petersen
Journal:  Curr Atheroscler Rep       Date:  2018-01-30       Impact factor: 5.113

2.  Whole milk compared with reduced-fat milk and childhood overweight: a systematic review and meta-analysis.

Authors:  Shelley M Vanderhout; Mary Aglipay; Nazi Torabi; Peter Jüni; Bruno R da Costa; Catherine S Birken; Deborah L O'Connor; Kevin E Thorpe; Jonathon L Maguire
Journal:  Am J Clin Nutr       Date:  2020-02-01       Impact factor: 7.045

3.  Dairy Product Consumption and Cardiovascular Health: a Systematic Review and Meta-Analysis of Prospective Cohort Studies.

Authors:  Zhangling Chen; Mavra Ahmed; Vanessa Ha; Katherine Jefferson; Vasanti Malik; Paula A B Ribeiro; Priccila Zuchinali; Jean-Philippe Drouin-Chartier
Journal:  Adv Nutr       Date:  2021-09-22       Impact factor: 11.567

4.  Dairy product consumption and calcified atherosclerotic plaques in the coronary arteries: The NHLBI Family Heart Study.

Authors:  Ulf Neisius; Guohai Zhou; Rachel E Ward; R Curtis Ellison; J Michael Gaziano; Luc Djoussé
Journal:  Clin Nutr ESPEN       Date:  2022-02-25

Review 5.  Microbiome-Mediated Effects of the Mediterranean Diet on Inflammation.

Authors:  Melisa A Bailey; Hannah D Holscher
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

6.  Olive Oil Consumption and Cardiovascular Risk in U.S. Adults.

Authors:  Marta Guasch-Ferré; Gang Liu; Yanping Li; Laura Sampson; JoAnn E Manson; Jordi Salas-Salvadó; Miguel A Martínez-González; Meir J Stampfer; Walter C Willett; Qi Sun; Frank B Hu
Journal:  J Am Coll Cardiol       Date:  2020-03-05       Impact factor: 24.094

7.  Potential Cardiometabolic Health Benefits of Full-Fat Dairy: The Evidence Base.

Authors:  Kristin M Hirahatake; Arne Astrup; James O Hill; Joanne L Slavin; David B Allison; Kevin C Maki
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

Review 8.  Dairy Foods: Is Its Cardiovascular Risk Profile Changing?

Authors:  Paul J Nestel; Trevor A Mori
Journal:  Curr Atheroscler Rep       Date:  2022-01-19       Impact factor: 5.113

9.  Dietary Factors Associated with Plasma Thyroid Peroxidase and Thyroglobulin Antibodies.

Authors:  Antonela Matana; Vesela Torlak; Dubravka Brdar; Marijana Popović; Bernarda Lozić; Maja Barbalić; Vesna Boraska Perica; Ante Punda; Ozren Polašek; Caroline Hayward; Tatijana Zemunik
Journal:  Nutrients       Date:  2017-10-28       Impact factor: 5.717

10.  Dietary supplementation with hybrid palm oil alters liver function in the common Marmoset.

Authors:  Flavia Spreafico; Rafael Carvalho Sales; Judit Gil-Zamorano; Priscylla da Costa Medeiros; Maria-Jesús Latasa; Monique Ribeiro Lima; Sergio Augusto Lopes de Souza; Roberto Martin-Hernández; Diego Gómez-Coronado; Eduardo Iglesias-Gutierrez; Diana C Mantilla-Escalante; Maria das Graças Tavares do Carmo; Alberto Dávalos
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.